Literature DB >> 21696897

Sodium Alginate (Gaviscon®) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants.

Luigi Corvaglia1, Monica Spizzichino, Daniele Zama, Arianna Aceti, Elisa Mariani, Elena Legnani, Giacomo Faldella.   

Abstract

BACKGROUND: Apnoea of prematurity (AOP) frequently recurs in preterm infants. We have previously shown that a significant but variable proportion of AOP is induced by gastro-oesophageal reflux (GOR). AIM: The aim of this study is to evaluate the efficacy of sodium alginate in reducing the frequency of GOR-related AOP.
SUBJECTS: Twenty-eight preterm infants with AOP were studied by a six-hour recording of combined multichannel intraluminal impedance and pH monitoring and polysomnography, including two three-hour postprandial periods: sodium alginate was given after one single meal named as drug-given (DG) meal, while the other as drug-free (DF).
RESULTS: During 165h of registration, 715 apnoeas were recorded, 368 after-DG and 347 after-DF (p=.99); furthermore, 851 GOR episodes were detected, 315 after-DG and 536 after-DF (p=.001). No differences in the number of AOP were found between DG and DF. A significant reduction in the number of acid GORs and in acid exposure was found during DG, while the administration of sodium alginate didn't influence non-acid GOR indexes. The frequency of GOR-related apnoeas didn't differ between DG and DF. DISCUSSION: Sodium alginate doesn't reduce the total number of AOP nor GOR-related apnoeas. On the other hand, it reduces acid GOR features, while it had no effect on non-acid GOR indexes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696897     DOI: 10.1016/j.earlhumdev.2011.05.013

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

Review 1.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 2.  Feed thickener for infants up to six months of age with gastro-oesophageal reflux.

Authors:  T'ng Chang Kwok; Shalini Ojha; Jon Dorling
Journal:  Cochrane Database Syst Rev       Date:  2017-12-05

3.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

4.  Pharmacological therapy of gastroesophageal reflux in preterm infants.

Authors:  Luigi Corvaglia; Caterina Monari; Silvia Martini; Arianna Aceti; Giacomo Faldella
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

5.  The Effect of Alginate in Gastroesophageal Reflux in Infants.

Authors:  Silvia Salvatore; Antonio Ripepi; Koen Huysentruyt; Kristel van de Maele; Luana Nosetti; Massimo Agosti; Alessandro Salvatoni; Yvan Vandenplas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

6.  Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review.

Authors:  Elda Dermyshi; Charley Mackie; Phoebe Kigozi; Bernard Schoonakker; Jon Dorling
Journal:  BMJ Paediatr Open       Date:  2018-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.